The new paradigms in the time of care to patients with head and neck cancer during the Covid-19 pandemic: a literature review

Victor Arthur Rodrigues de Souza, Gabriel Santos Neves, Gustavo Henrique Santos de Almeida, Carlos Eduardo Palanch Repeke

Abstract


Introduction: SARS-CoV2 is a worldwide health threat, which has as its main risk group patients with head and neck cancer. In the time being and in the chance of an emerging second wave of infection, a new protocol based on when to treat patients with head and neck cancer must be implemented. Aim: Reporting the handling protocols for patients with head and neck cancer, facilitating the clinician's decision in the pandemic scenario. Materials and Methods: A bibliographic search was performed in PubMed. A search strategy with descriptors was applied to the database, aiming at reaching scientific articles. The articles reached in such database had their titles and abstracts read in search for the adequacy to the objective proposed. Only scientific articles published between December 1st 2019, and July 10th 2020, were chosen. There was no restriction either on country or language. Literature review: New protocols were created based on the type and stage of cancer, classifying them in order to identify the ideal time to operate safely. Thus, the protocol has levels from initial to advanced, where the initial level comprises benign neoplasms, skin cancers smaller than 2 mm and cases in asymptomatic early stages, and the advanced level comprises malignant, aggressive neoplasms, with painful symptoms and/or that are compromising the other systems and organs. Conclusion: It is necessary to follow the detailed care protocol to guide the progress of head and neck cancer services, by operating patients immediately or postponing surgery, depending on the case and seriousness.

Keywords


Coronavirus infections; Head and neck neoplasms; Betacoronavirus

Full Text:

PDF

References


World Health Organization. Clinical management of COVID-19: interim guidance, 27 May 2020. World Health Organization; 2020.

Sobre a doença [Internet]. Brasil: Ministério da Saúde; 2020 [acesso em 10 jul. 2020]. Disponível em: https://coronavirus.saude.gov.br/index.php/sobre-a-doenca.

Folha informativa COVID-19 - Escritório da OPAS e da OMS no Brasil [Internet]. Organização Pan-Amerinaca de Saúde. Escritório Regional para as Américas da Organização Mundial da Saúde; 2020 [acesso em 14 jul. 2020]. Disponível em: https://www.paho.org/bra/index.php?option=com_content&view=article&id=6101:covid19&Itemid=875.

Considerations for the Reorganization of Cancer Services during the COVID-19 Pandemic [Internet]. Pan American Health Organization; 2020 [cited 2020 Jul. 14];1–18. Available from: https://iris.paho.org/handle/10665.2/52263.

Taylor R, Omakobia E, Sood S, Glore RJ. The impact of coronavirus disease 2019 on head and neck cancer services: a UK tertiary centre study. J Laryngol Otol. 2020;134(8):684–7.

Yuen E, Fote G, Horwich P, Nguyen SA, Patel R, Davies J, et al. Head and neck cancer care in the COVID-19 pandemic: a brief update. Oral Oncol. 2020;105:104738.

Maniakas A, Jozaghi Y, Zafereo ME, Sturgis EM, Su SY, Gillenwater AM, et al. Head and neck surgical oncology in the time of a pandemic: subsite-specific triage guidelines during the COVID-19 pandemic. Head Neck. 2020;42(6):1194–201.

Mojic M, Takeda K, Hayakawa Y. The dark side of IFN-γ: Its role in promoting cancer immunoevasion. Int J Mol Sci. 2017;19(1):89.

Mandai M, Hamanishi J, Abiko K, Matsumura N, Baba T, Konishi I. Dual faces of IFNγ in cancer progression: a role of PD-L1 induction in the determination of pro- and antitumor immunity. Clin Cancer Res. 2016 May 15;22(10):2329-34.

Martin-Hijano L, Sainz B Jr. The interactions between cancer stem cells and the innate interferon signaling pathway. Front. Immunol. 2020. 11:526.

Su S, Jiang S. A suspicious role of interferon in the pathogenesis of SARS-CoV-2 by enhancing expression of ACE2. Signal Transduct Target Ther. 2020;5(1):3–4.

Day AT, Sher DJ, Lee RC, Truelson JM, Myers LL, Sumer BD, et al. Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks. Oral Oncol. 2020;105:104684.

Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020 Aug 7;369(6504):718-24.

Lei X, Dong X, Ma R, Wang W, Xiao X, Tian Z, et al. Activation and evasion of type I interferon responses by SARS-CoV-2. Nat Commun. 2020;11(1):1–12.

Hu KH, Krummel MF. Carpet-bombing tumors with IFN-γ. Nat Cancer. 2020;1(3).

Ranasinghe V, Mady LJ, Kim S, Ferris RL, Duvvuri U, Johnson JT, et al. Major head and neck reconstruction during the COVID-19 pandemic: The University of Pittsburgh approach. Head & Neck. 2020;42(6):1243-7.

Topf MC, Shenson JA, Holsinger FC, Wald SH, Cianfichi LJ, Rosenthal EL, et al. Framework for prioritizing head and neck surgery during the COVID-19 pandemic. Head Neck. 2020;42(6):1159–67.

Morrison DR, Gentile C, McCammon S, Buczek E. Head and neck oncologic surgery in the COVID-19 pandemic: our experience in a deep south tertiary care center. Head & Neck. 2020;42(7):1471–6.




DOI: https://doi.org/10.22456/2177-0018.107527

Licença Creative Commons

e-ISSN 2177-0018 / ISSN 0566-1854.

descrição da foto descrição da foto descrição da foto descrição da foto descrição da foto descrição da foto descrição da fotodescrição da foto